ALT Cannabis Announce Agreement with Grow Group for Expansion into European Medical Cannabis Markets
3 min readPublished On: August 18th, 2021By News Team
LOS ANGELES–Pioneering liquid cannabis company ALT (Advanced Liquid Technology), announced it has entered into an agreement with Grow (Grow Group Plc) to market and distribute ALT’s proprietary, fast-acting, liquid medical cannabis products across Europe.
ALT uses emulsion technology to create unique flavor neutral, zero calorie, sugar-free, vegan, keto, and paleo friendly water-compatible medical cannabis products in the form of nanoemulsions, which are kinetically stable with an incredibly small particle size. ALT’s technology allows for far more effective delivery of cannabinoids to the user, compared to tinctures and other ingestible products.
Patients will benefit from rapid on-set of effects within 5-15 minutes in addition to higher efficiency in absorption of medical cannabis. ALT finally enables doctors to recommend precise doses of cannabinoids to patients based on their individual need for relief from an array of ailments. ALT’s products are designed to allow patients to titrate their dose accordingly.
ALT plans to have a range of EU GMP-certified liquid medical cannabis products available for patients in Europe by early 2022. Medical patients will have access to ALT’s products by obtaining prescriptions through private practice or national health services.
Grow Group’s CEO Ben Langley said that “GROW’s mission is to bring medical cannabis products to all patients who need them. We strive to constantly improve and innovate on our product offering. With our leading position and unique experience we are very confident that with ALT’S new mode of administration, using liquid medical cannabis, we are going to make another leap forward in providing patients with the best products and solutions for their symptom management.”
(Mr. Robert Davis CEO of ALT)
ALT’s CEO, Robert Davis, commented, “We are honored to partner with GROW in bringing ALT’s completely differentiated brand and liquid medical cannabis technologies to the European medical markets. After successfully launching ALT into California in December of 2020, we are excited to expand internationally, our first step towards becoming a global brand. ALT’s mission is to Enhance Human Potential and we will do so, one patient at a time, through the power of our liquid cannabis platform.”
About Grow Group and Grow Pharma UK
Grow Pharma is a leading UK medical cannabis distributor and part of the Grow Group. Grow Group PLC exists to unlock the medical potential of cannabis for those who need it. Grow works with the producers of the best cannabis-based medicines and helps them introduce their products in markets like the U.K. and Ireland, creating long-term value for them and offering solutions for patients.
The Grow team also focuses on supporting clinics and individual healthcare professionals. Through a U.K. partnership with IPS Specials Pharma, Grow works with the best importer, distributor and pharmacy in the country to deliver the medication to patients. Ultimately, all Grow Group activities are aimed at improving patient access to cannabis medicines. Find out more at www.growgroupplc.com.
ALT fuses nature with science to Enhance Human Potential™ through precision liquid cannabis. ALT delivers healthier, elevated, and consistent medical cannabis products without the common drawbacks of other delivery methods––be it the delayed onset of ingestibles, tinctures, and oils or the known health risks associated with vaporizing or smoking cannabis.
ALT is incorporated in Delaware, with operations headquartered in Los Angeles, California. Find out more at www.altlife.com.
(This information is primarily sourced from ALT. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
Douglas, Isle Of Man - Cannabis extraction and extract have gone through exponential growth in the past decade. After being criminalized for a long time, the world saw and moved towards legalizing cannabis in many ...
GRANTS, N.M. - Bright Green Corporation (NASDAQ: BGXX) (“Bright Green” or “the Company”), one of the very few companies selected by the U.S. government to grow, manufacture, and sell, legally under federal and state laws, ...
DUBLIN - Global Cannabis Testing Market to Reach $2.8 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Cannabis Testing estimated at US$1.1 Billion in the year 2022, is projected to reach ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more